Valeant Buys Sprout Pharmaceuticals

Valeant announced on Aug. 20, 2015 that it will acquire Sprout Pharmaceuticals. The announcement comes a day after Sprout won FDA approval for the first-ever drug targeting low libido in women. The female sexual dysfunction pill from Sprout Addyi (flibanserin) is being casually referred to as thOriginal Article